Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Pulsoni

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
Cancer|December 20, 2011
Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas: phase 2 study of the Italian Lymphoma FoundationAndrea Ferrario, Alessandro Pulsoni, Barbara Olivero, et al.
British Journal of Haematology|August 7, 2019
Minimal residual disease monitoring in early stage follicular lymphoma can predict prognosis and drive treatment with rituximab after radiotherapyAlessandro Pulsoni, Irene Della Starza, Luca V Cappelli, et al.
La Radiologia Medica|May 5, 2023
Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomasFrancesca Maccioni, Giulia Alfieri, Giovanni Manfredi Assanto, et al.
Blood|October 27, 2011
Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutationEnrico Tiacci, Gianluca Schiavoni, Francesco Forconi, et al.
Frontiers in Oncology|May 8, 2023
Effects of ABVD chemotherapy on ovarian function: epidemiology, hormonal dosages and ultrasound morphologic analyses in 270 patients with Hodgkin's diseaseMariavita Ciccarone, Paola Cavaceppi, Cristiano Tesei, et al.
Genes and Immunity|February 19, 2020
A stereotyped light chain may shape virus-specific B-cell receptors in HCV-dependent lymphoproliferative disordersYlenia A Minafò, Martina Del Padre, Cristina Cristofoletti, et al.
Annals of Hematology|August 31, 2023
High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from ItalyMarcella Visentini, Andrea Pica, Giancarlo D'Ippolito, et al.
Frontiers in Immunology|July 26, 2024
Surface antigen serocleared hepatitis B virus infection increases the risk of mixed cryoglobulinemia vasculitis in male patients with chronic hepatitis CAnna Morrone, Valerio Fiorilli, Lilia Cinti, et al.
Leukemia & Lymphoma|March 21, 2015
Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II studyEmilio Iannitto, Stefano Luminari, Claudio Tripodo, et al.
Blood|January 8, 2005
Quantitative PCR of bone marrow BCL2/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphomaAlessandro Rambaldi, Emanuela Carlotti, Elena Oldani, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Cancer|December 20, 2011
Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas: phase 2 study of the Italian Lymphoma FoundationAndrea Ferrario, Alessandro Pulsoni, Barbara Olivero, et al.
British Journal of Haematology|August 7, 2019
Minimal residual disease monitoring in early stage follicular lymphoma can predict prognosis and drive treatment with rituximab after radiotherapyAlessandro Pulsoni, Irene Della Starza, Luca V Cappelli, et al.
La Radiologia Medica|May 5, 2023
Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomasFrancesca Maccioni, Giulia Alfieri, Giovanni Manfredi Assanto, et al.
Blood|October 27, 2011
Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutationEnrico Tiacci, Gianluca Schiavoni, Francesco Forconi, et al.
Frontiers in Oncology|May 8, 2023
Effects of ABVD chemotherapy on ovarian function: epidemiology, hormonal dosages and ultrasound morphologic analyses in 270 patients with Hodgkin's diseaseMariavita Ciccarone, Paola Cavaceppi, Cristiano Tesei, et al.
Genes and Immunity|February 19, 2020
A stereotyped light chain may shape virus-specific B-cell receptors in HCV-dependent lymphoproliferative disordersYlenia A Minafò, Martina Del Padre, Cristina Cristofoletti, et al.
Annals of Hematology|August 31, 2023
High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from ItalyMarcella Visentini, Andrea Pica, Giancarlo D'Ippolito, et al.
Frontiers in Immunology|July 26, 2024
Surface antigen serocleared hepatitis B virus infection increases the risk of mixed cryoglobulinemia vasculitis in male patients with chronic hepatitis CAnna Morrone, Valerio Fiorilli, Lilia Cinti, et al.
Leukemia & Lymphoma|March 21, 2015
Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II studyEmilio Iannitto, Stefano Luminari, Claudio Tripodo, et al.
Blood|January 8, 2005
Quantitative PCR of bone marrow BCL2/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphomaAlessandro Rambaldi, Emanuela Carlotti, Elena Oldani, et al.
Pageof 11